Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Current Leases (2019 - 2025)

OptimizeRx (OPRX) has disclosed Current Leases for 7 consecutive years, with $193000.0 as the latest value for Q4 2025.

  • Quarterly Current Leases rose 14.88% to $193000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $193000.0 through Dec 2025, up 14.88% year-over-year, with the annual reading at $193000.0 for FY2025, 14.88% up from the prior year.
  • Current Leases hit $193000.0 in Q4 2025 for OptimizeRx, down from $207000.0 in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $233000.0 in Q1 2024 to a low of $14545.0 in Q2 2023.
  • Historically, Current Leases has averaged $134541.4 across 5 years, with a median of $114830.0 in 2021.
  • Biggest five-year swings in Current Leases: crashed 83.41% in 2023 and later soared 1405.67% in 2024.
  • Year by year, Current Leases stood at $90982.0 in 2021, then dropped by 1.19% to $89902.0 in 2022, then soared by 146.94% to $222000.0 in 2023, then dropped by 24.32% to $168000.0 in 2024, then increased by 14.88% to $193000.0 in 2025.
  • Business Quant data shows Current Leases for OPRX at $193000.0 in Q4 2025, $207000.0 in Q3 2025, and $209000.0 in Q2 2025.